RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Abraxis Bioscience Llc patents

Recent patent applications related to Abraxis Bioscience Llc. Abraxis Bioscience Llc is listed as an Agent/Assignee. Note: Abraxis Bioscience Llc may have other listings under different names/spellings. We're not affiliated with Abraxis Bioscience Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abraxis Bioscience Llc-related inventors




Date Abraxis Bioscience Llc patents (updated weekly) - BOOKMARK this page
06/22/17 new patent  Nanoparticle formulations and uses thereof
06/08/17Intravascular delivery of nanoparticle compositions and uses thereof
04/20/17Combination therapy with thiocolchicine derivatives
04/13/17Prion free nanoparticle compositions and methods of making thereof
02/23/17Methods of treatment of pancreatic cancer
01/26/17Methods of treating pancreatic cancer
01/19/17Methods of treating cancer
01/12/17Compositions and methods for preparation of poorly water soluble drugs with increased stability
12/29/16Methods of treatment of hepatocellular carcinoma
10/20/16Sparc binding scfvs
08/25/16Sparc and methods of use thereof
08/11/16Methods of treating melanoma
06/09/16Methods and compositions for treating recurrent cancer
06/02/16Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
01/21/16Methods of treating lung cancer
01/21/16Methods of treatment of pediatric solid tumor
01/14/16Methods of treating bladder cancer
11/05/15Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
07/09/15Sparc and methods of use thereof
07/09/15Compositions and methods for treatment of hyperplasia
07/09/15Drugs with improved hydrophobicity for incorporation in medical devices
06/18/15Compositions and methods of delivery of pharmacological agents
06/11/15Use of polymeric excipients for lyophilization or freezing of particles
04/23/15Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
04/16/15Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
03/19/15Methods and compositions for treating proliferative diseases
03/19/15Methods and compositions for treating recurrent cancer
02/19/15Nanoparticle comprising rapamycin and albumin as anticancer agent
12/18/14Sparc binding scfvs
11/20/14Sparc binding scfvs
11/20/14Sparc binding scfvs
10/09/14Nanoparticle formulations and uses therof
10/02/14Intravascular delivery of nanoparticle compositions and uses thereof
10/02/14Prion free nanoparticle compositions and methods of making thereof
09/18/14Methods and compositions for treating pulmonary hypertension
07/17/14Methods of treating pancreatic cancer
07/17/14Method for treating cancer based on level of a nucleoside transporter
07/03/14Nanoparticle compositions of albumin and paclitaxel
06/19/14Combination therapy methods for treating proliferative diseases
05/15/14Methods of treating melanoma
04/03/14Sparc angiogenic domain and methods of use
03/20/14Methods for treating hepatocellular carcinoma
03/20/14Methods of treatment of pancreatic cancer
03/20/14Combinations and modes of administration of therapeutic agents and combination therapy
03/20/14Nanoparticle formulations and uses thereof
03/13/14Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
03/13/14Combinations and modes of administration of therapeutic agents and combination therapy
03/13/14Methods of treating cancer
02/27/14Methods of treating bladder cancer
02/06/14Compositions and methods of delivery of pharmacological agents
02/06/14Compositions and methods of delivery of pharmacological agents
01/23/14Methods and compositions for treating proliferative diseases
01/16/14Methods and compositions for treeating proliferative diseases
01/16/14Methods and compositions for treating recurrent cancer
01/16/14Methods of enhancing drug delivery and effectiveness of therapeutic agents
12/05/13Sparc angiogenic domain and methods of use
11/28/13Sparc binding peptides and uses thereof
10/24/13Sparc microenvironment signature, plasma sparc, and ldh as prognostic biomarkers in the treatment of cancer
09/19/13Compositions and methods of delivery of pharmacological agents
08/01/13Sparc binding aptamers and uses thereof
08/01/13Methods and compositions for treating proliferative diseases
08/01/13Combinations and modes of administration of therapeutic agents and combination therapy
07/04/13Use of 2 anti-sparc antibodies to predict response to chemotherapy
04/25/13Sparc binding antibodies and uses thereof
02/21/13Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
Patent Packs
09/27/12Use of the sparc microenvironment signature in the treatment of cancer
07/19/12Sparc antisense compositions and uses thereof
04/12/12Sparc angiogenic domain and methods of use
03/01/12Peripheral blood sparc binding antibodies and uses thereof
02/16/12Sparc binding peptides and uses thereof
01/26/12Use of the sparc microenvironment signature in the treatment of cancer
01/19/12Sparc binding scfvs
01/12/12Albumin binding peptide-mediated disease targeting
06/23/11Triazine derivatives and their therapeutical applications
03/31/11Lens arrays and methods of making the same
01/13/11Q3 sparc deletion mutant and uses thereof
12/09/10Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/02/10Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
11/04/10Dicarbonyl derivatives and methods of use
05/06/10Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
Patent Packs
11/12/09Enhancement of drug therapy by mirna
09/03/09Treatment, diagnostic, and discovering antagonist using sparc specific mirnas







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abraxis Bioscience Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abraxis Bioscience Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';